Growth Metrics

Rh (RH) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Rh (RH) over the last 15 years, with Q4 2025 value amounting to 11.99%.

  • Rh's EBITDA Margin fell 5100.0% to 11.99% in Q4 2025 from the same period last year, while for Nov 2025 it was 10.59%, marking a year-over-year increase of 4000.0%. This contributed to the annual value of 10.14% for FY2025, which is 19400.0% down from last year.
  • Latest data reveals that Rh reported EBITDA Margin of 11.99% as of Q4 2025, which was down 5100.0% from 14.33% recorded in Q3 2025.
  • In the past 5 years, Rh's EBITDA Margin ranged from a high of 27.08% in Q4 2021 and a low of 6.82% during Q4 2023
  • Over the past 5 years, Rh's median EBITDA Margin value was 14.43% (recorded in 2023), while the average stood at 16.07%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first soared by 144900bps in 2021, then plummeted by -127700bps in 2023.
  • Rh's EBITDA Margin (Quarter) stood at 27.08% in 2021, then decreased by -28bps to 19.59% in 2022, then tumbled by -65bps to 6.82% in 2023, then soared by 83bps to 12.5% in 2024, then fell by -4bps to 11.99% in 2025.
  • Its EBITDA Margin stands at 11.99% for Q4 2025, versus 14.33% for Q3 2025 and 6.87% for Q2 2025.